These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

968 related articles for article (PubMed ID: 35175435)

  • 21. Recent progress in upconversion luminescence nanomaterials for biomedical applications.
    Duan C; Liang L; Li L; Zhang R; Xu ZP
    J Mater Chem B; 2018 Jan; 6(2):192-209. PubMed ID: 32254163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Near-Infrared-Triggered Upconverting Nanoparticles for Biomedicine Applications.
    Mahata MK; De R; Lee KT
    Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34210059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orthogonal Emissive Upconversion Nanoparticles: Material Design and Applications.
    Zhang Z; Zhang Y
    Small; 2021 Mar; 17(11):e2004552. PubMed ID: 33543556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioapplications and biotechnologies of upconversion nanoparticle-based nanosensors.
    Wang C; Li X; Zhang F
    Analyst; 2016 Jun; 141(12):3601-20. PubMed ID: 26978012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Energy Flux Manipulation in Upconversion Nanosystems.
    Liang L; Qin X; Zheng K; Liu X
    Acc Chem Res; 2019 Jan; 52(1):228-236. PubMed ID: 30557000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging NIR light-responsive delivery systems based on lanthanide-doped upconverting nanoparticles.
    Le XT; Youn YS
    Arch Pharm Res; 2020 Jan; 43(1):134-152. PubMed ID: 31981073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lanthanide-Doped Upconversion Luminescent Nanoparticles-Evolving Role in Bioimaging, Biosensing, and Drug Delivery.
    Jethva P; Momin M; Khan T; Omri A
    Materials (Basel); 2022 Mar; 15(7):. PubMed ID: 35407706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for Constructing Upconversion Luminescence Nanoprobes to Improve Signal Contrast.
    Li Z; Liang T; Wang Q; Liu Z
    Small; 2020 Jan; 16(1):e1905084. PubMed ID: 31782913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering DNA on the Surface of Upconversion Nanoparticles for Bioanalysis and Therapeutics.
    Zhang D; Peng R; Liu W; Donovan MJ; Wang L; Ismail I; Li J; Li J; Qu F; Tan W
    ACS Nano; 2021 Nov; 15(11):17257-17274. PubMed ID: 34766752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in design and fabrication of upconversion nanoparticles and their safe theranostic applications.
    Gu Z; Yan L; Tian G; Li S; Chai Z; Zhao Y
    Adv Mater; 2013 Jul; 25(28):3758-79. PubMed ID: 23813588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upconversion nanoparticles and their composite nanostructures for biomedical imaging and cancer therapy.
    Cheng L; Wang C; Liu Z
    Nanoscale; 2013 Jan; 5(1):23-37. PubMed ID: 23135546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lanthanide-Doped Nanoparticles with Upconversion and Downshifting Near-Infrared Luminescence for Bioimaging.
    Cao C; Liu Q; Shi M; Feng W; Li F
    Inorg Chem; 2019 Jul; 58(14):9351-9357. PubMed ID: 31246450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging ≈800 nm Excited Lanthanide-Doped Upconversion Nanoparticles.
    Xie X; Li Z; Zhang Y; Guo S; Pendharkar AI; Lu M; Huang L; Huang W; Han G
    Small; 2017 Feb; 13(6):. PubMed ID: 27982542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lanthanide-doped upconversion nano-bioprobes: electronic structures, optical properties, and biodetection.
    Zheng W; Huang P; Tu D; Ma E; Zhu H; Chen X
    Chem Soc Rev; 2015 Mar; 44(6):1379-415. PubMed ID: 25093303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biosafety of lanthanide upconversion nanomaterials.
    Sun Y; Feng W; Yang P; Huang C; Li F
    Chem Soc Rev; 2015 Mar; 44(6):1509-25. PubMed ID: 25113504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lanthanide-doped LiLuF(4) upconversion nanoprobes for the detection of disease biomarkers.
    Huang P; Zheng W; Zhou S; Tu D; Chen Z; Zhu H; Li R; Ma E; Huang M; Chen X
    Angew Chem Int Ed Engl; 2014 Jan; 53(5):1252-7. PubMed ID: 24436151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in lanthanide-doped upconversion nanomaterials: synthesis, nanostructures and surface modification.
    Qiu P; Zhou N; Chen H; Zhang C; Gao G; Cui D
    Nanoscale; 2013 Dec; 5(23):11512-25. PubMed ID: 24121736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upconversion luminescent nanomaterials: A promising new platform for food safety analysis.
    Abdul Hakeem D; Su S; Mo Z; Wen H
    Crit Rev Food Sci Nutr; 2022; 62(32):8866-8907. PubMed ID: 34159870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maximizing Upconversion Luminescence of Co-Doped CaF₂:Yb, Er Nanoparticles at Low Laser Power for Efficient Cellular Imaging.
    Dubey N; Gupta S; Shelar SB; Barick KC; Chandra S
    Molecules; 2024 Sep; 29(17):. PubMed ID: 39275024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifunctional nanomesoporous materials with upconversion (in vivo) and downconversion (in vitro) luminescence imaging based on mesoporous capping UCNPs and linking lanthanide complexes.
    Sun L; Ge X; Liu J; Qiu Y; Wei Z; Tian B; Shi L
    Nanoscale; 2014 Nov; 6(21):13242-52. PubMed ID: 25263544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.